Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
So basically your argument is the company announced they applied for EUA and you plug your ears with your fingers, shake your head and say nuh-un no they didn't??
See I agree with that too, you sound very unsure. Here's the thing, djjazziejeff doesn't get a say in what the FDA does, the FDA determines approval, nothing has been shut down the process is ongoing right now and one of a number of different countries will approve Leronlimab for EUA
I agree this is beyond you. I also find it amusing how terrified people get when CytoDyn applies for EUA.
Ok...so you're using the term "data mining" to try and turn CytoDyn's positive data into a negative, while trying to prove I'm wrong that the shorts use the term "data mining" to try and spin positive data into a negative...ok... gotcha...makes sense now.
The term "data mining" is a tool shorts use to distract from positive results. You'll see it being used when trying to draw attention away from positive data.
Absolutely, at this point the only question is who will approve first.
Canada is reviewing Leronlimab for EUA. So yeah, EUA is kind of a big deal
So after reading this it looks like hgen has discovered the secret to curing covid-19, very impressive. But kind of puzzling why is hgen tanking?
Looking for Longhaulers PR this weekend
And when the EUA is approved by the FDA CYDY will easily gap to double digits.
So what you're saying here is CytoDyn will now get the same consideration as Gilead??!! I have to agree with you on this one, Gilead received approval for Rem which is junk, so that pretty much is a lock for CYDY approval.
It's an approval that would allow CytoDyn to sell Vyrologix. Meaning CytoDyn will be open for business and will launch the start of billions $ of revenue. CYDY will be a triple digit stock.
Not to mention Mayo Clinic is involved. If they can't get a trial filled with that type of heavyweight there must be some serious problems. Unlike Leronlimab who completed their trial and showed positive results.
The changes are for EUA in age related subset of patients.
Either way it appears to being groomed for an approval, be it EUA with phase 4 or just EUA now. Which ever way it goes it will be soon
Wow! This looks like changes to support conditional approval.
There's another that is citing the Citron report as their evidence. The report that doesn't even exist. It's amazing that a law firm would be so stupid.
Bronstein, Gewirtz & Grossman, LLC
"On June 30, 2020, Citron Research published a report entitled, "SEC Must Immediately Halt this Stock Promotion Scheme." The Citron Research report stated that "[t]his is a $5 billion market cap company"
CytoDyn owns the most valuable clinical data to treat covid-19 than any other pharma company. Vyrologix will be approved for EUA
CD10
CD12
CD15
CD16
It's a cash grab, they are collecting retainers from anyone stupid enough to write them a check.
Here's a fact for you CD12 is still recruiting, OLE still approved, eIND still approved. The only reason for this is CD12 DID NOT FAIL.
EUA will be approved for Vyrologix and CYDY will be a three digit stock
Lol.. and yet another indication... rabies
“I don’t know if I’m getting the actual drug or not,” he said. Musser said he is in touch with participants in a similar trial in Georgia who told him their symptoms have improved from Leronlimab."
https://www.sun-sentinel.com/coronavirus/fl-ne-covid-long-haulers-20210320-w6l6g76fu5guti33ablez2ybm4-story.html?outputType=amp
CEO of Texas Roadhouse commits suicide because of covid symptoms. Hopefully CD15 will prove effective.
https://news.yahoo.com/texas-roadhouse-ceo-died-suicide-215500079.html
I'm thinking the same, I expect excellent results from the cancer trial but news will develop slowly, typically a cancer patient is screened every 3 to 6 months.
NASH trial updated today and estimated completion date is 3/22
Very good! NASH trial, updated today, completion date is 3/22
Looks like Mondays CC might have big news!!
"leronsaline?" I guess if one can't produce proof CD12 failed one can always resort to name calling.
Conditional approval...sounds even better. Leronlimab will be approved for sale while conducting CD16. The data is there to support it and others have been approved with much less. Call it what you want either way CytoDyn will be open for business.
It's been about two weeks since they requested a meeting and that's about the timeline for the FDA to get one scheduled. The positive part of the PR is "conditional EUA", CD12 certainly has enough positive data to support an EUA while they conduct CD16. My guess is they filed for the conditional EUA with the protocol for CD16.
"RECENT conditional EUA filing"
recent COVID-19 related filings for Conditional EUA with the FDA in U.S., Interim Order in Canada, and accelerated rolling review in U.K., as well as potential similar filings in Brazil and the Philippines.
Bought more shares, pending PR's due anytime
So when Leronlimab shows excellent results in all sites along with Recknor's there will be no question.
Makes sense, fits the time line from tld and the only logical reason for not answering the phone today.
Management is in London finalizing contracts for approval and sell of Leronlimab.
CYDY is up 25% in less than a week. More to come, L/H PR due to drop at any time.
It fits the timeline. Typically takes 2 weeks to get a meeting with a regulatory agency.
Could be a pending announcement? Maybe io from Canada?
Ask Mark Terry how to spell NP's name I'm sure he interviewed him when he wrote this article. And gave CytoDyn top billing
https://www.biospace.com/article/clinical-catch-up-march-8-12/